Undisclosed Small Molecule Programs

About BIOM Pharmaceutical

BIOM Pharmaceutical is a private, preclinical-stage biotech harnessing the human microbiome to develop small molecule drugs for oncology and inflammatory conditions. Its core technology platform is designed to modulate the microbiome's metabolic output to address a wide range of diseases, positioning it at the intersection of microbiome science and traditional drug discovery. The company appears to be pre-revenue, focusing on R&D with a vision for both pharmaceutical and nutritional product development. Its strategic location in San Diego provides access to a rich biotech ecosystem.

Therapeutic Areas